Form D · Biotechnology
Implicit Bioscience Inc
Seattle, WA · CIK 0001594821
Offering snapshot reported Dec 20, 2013 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-208405
Source: Form D, filed Dec 20, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lee Lawrence Huntsman | Director |
| Marion Koster | Executive |
| Norman Lemay | Director |
| Garry Llewellyn Redlich | Director |
| James Edward Rottsolk | Director |
| Daniel David Syrdal | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
550 17 Th Ave James Tower Ste 235
Seattle, WA, 98122
Seattle, WA, 98122